Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Pre-Tax Income

: $330 Mil (TTM As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

Pretax income is the income that a company earns before paying income taxes. Aspen Pharmacare Holdings's pretax income for the six months ended in Dec. 2023 was $156 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $330 Mil. Aspen Pharmacare Holdings's pretax margin was 13.76%.

During the past 13 years, Aspen Pharmacare Holdings's highest Pretax Margin was 21.54%. The lowest was 6.62%. And the median was 16.62%.

Aspen Pharmacare Holdings Pre-Tax Income Historical Data

The historical data trend for Aspen Pharmacare Holdings's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Pre-Tax Income

Get a 7-Day Free Trial

161.19

245.01

430.46

514.34

349.70

Aspen Pharmacare Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															263.91	249.14	190.86	173.76	156.07

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aspen Pharmacare Holdings Pre-Tax Income Distribution

For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Aspen Pharmacare Holdings's Pre-Tax Income falls into.

Aspen Pharmacare Holdings Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Aspen Pharmacare Holdings's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	477.092	+	0	+	-70.633	+	27.154	+	-83.916
	=	350

Aspen Pharmacare Holdings's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	187.841	+	0	+	-53.132	+	25.117	+	-3.757
	=	156

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $330 Mil.

Aspen Pharmacare Holdings (OTCPK:APNHY) Pre-Tax Income Explanation

Aspen Pharmacare Holdings's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	156.069	/	1134.612
	=	13.76%

During the past 13 years, Aspen Pharmacare Holdings's highest Pretax Margin was 21.54%. The lowest was 6.62%. And the median was 16.62%.

Aspen Pharmacare Holdings Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHY) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

APN:South Africa

Address

Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF

Website

https://www.aspenpharma.com

Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos • 03-17-2019

Aspiring for Aspen Pharmacare Holdings Ltd's Dividend: A Comprehensive Analysis

By GuruFocus Research • 09-21-2023